Literature DB >> 8147645

Effect of cardiopulmonary bypass on early graft dysfunction in clinical lung transplantation.

R Aeba1, B P Griffith, R L Kormos, J M Armitage, T A Gasior, C R Fuhrman, S A Yousem, R L Hardesty.   

Abstract

The records of 100 lung transplant recipients (13 heart-lungs, 45 double-lungs, and 42 single-lungs) from September 1990 through April 1992 were reviewed to determine the role of cardiopulmonary bypass (CPB) in early graft dysfunction. Fifty-five patients requiring CPB (CPB group) for 186 +/- 54 minutes were compared with the 45 patients without CPB (no-CPB group). All of the heart-lung and en-bloc double-lung transplantations were performed under CPB, with pulmonary vascular lung disease the principal diagnosis, resulting in a significantly younger age population in the CPB group. All other donor- and recipient-related factors matched well in both groups. Of 38 bilateral single-lung transplantations, CPB was used in 18. In double-lung and heart-lung recipients gas exchange of the allografts was evaluated by the arterial/alveolar oxygen tension ratios at nine intervals during the first 72 hours. The mean arterial/alveolar oxygen tension ratio in the CPB group was 0.48 +/- 0.19, significantly lower than in the no-CPB group with 0.60 +/- 0.22 (p = 0.025). All patients had radiographic interpretation and scoring of pulmonary infiltrates from chest roentgenograms taken within 12 hours after reperfusion. The CPB group had more severe pulmonary infiltrates than the no-CPB group (p = 0.034). Prolonged intubation defined as 7 days or longer occurred significantly more often (29/55) in the CPB group than in the no-CPB group (8/45) (p = 0.003). Actuarial graft and patient survival at 1 month was better in the no-CPB group than in the CPB group (42/45 versus 44/55 [p = 0.05] and 43/45 versus 45/55 [p = 0.033], respectively).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8147645     DOI: 10.1016/0003-4975(94)90573-8

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  16 in total

1.  Acute Kidney Injury in Patients Undergoing Cardiopulmonary Bypass for Lung Transplantation.

Authors:  Christopher A Heid; Mitri K Khoury; Kayla Maaraoui; Charles Liu; Matthias Peltz; Michael A Wait; W Steves Ring; Lynn C Huffman
Journal:  J Surg Res       Date:  2020-06-26       Impact factor: 2.192

Review 2.  Established and potential predictors of blood loss during lung transplant surgery.

Authors:  Pascal Oechslin; Marco P Zalunardo; Ilhan Inci; Martin Schlaepfer; Bastian Grande
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

3.  Acute hyperglycemic exacerbation of lung ischemia-reperfusion injury is mediated by receptor for advanced glycation end-products signaling.

Authors:  Damien J Lapar; Vanessa A Hajzus; Yunge Zhao; Christine L Lau; Brent A French; Irving L Kron; Ashish K Sharma; Victor E Laubach
Journal:  Am J Respir Cell Mol Biol       Date:  2011-10-06       Impact factor: 6.914

Review 4.  New horizons of non-emergent use of extracorporeal membranous oxygenator support.

Authors:  George Makdisi; Peter B Makdisi; I-Wen Wang
Journal:  Ann Transl Med       Date:  2016-02

5.  Extracorporeal membrane oxygenation versus cardiopulmonary bypass during lung transplantation: a meta-analysis.

Authors:  Dimitrios E Magouliotis; Vasiliki S Tasiopoulou; Alexis A Svokos; Konstantina A Svokos; Dimitris Zacharoulis
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-09-16

6.  Pretreatment strategy with adenosine A2A receptor agonist attenuates reperfusion injury in a preclinical porcine lung transplantation model.

Authors:  Damien J LaPar; Victor E Laubach; Abbas Emaminia; Ivan K Crosby; Vanessa A Hajzus; Ashish K Sharma; Heather M Sumner; David V Webb; Christine L Lau; Irving L Kron
Journal:  J Thorac Cardiovasc Surg       Date:  2011-07-16       Impact factor: 5.209

7.  Comparison of single lung transplant with and without the use of cardiopulmonary bypass.

Authors:  Clare Burdett; Tanveer Butt; Jim Lordan; John H Dark; Stephen C Clark
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-06-19

Review 8.  Pathophysiology and classification of primary graft dysfunction after lung transplantation.

Authors:  Morvern Isabel Morrison; Thomas Leonard Pither; Andrew John Fisher
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

9.  Advances in lung transplantation.

Authors:  V G Valentine; P M McFadden; J L Ochsner
Journal:  Ochsner J       Date:  1999-01

Review 10.  Overview of lung transplantation.

Authors:  Marlyn S Woo
Journal:  Clin Rev Allergy Immunol       Date:  2008-12       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.